Elira

St. Louis, United States Founded: 2004 • Age: 22 yrs
Wearable neurostimulation devices for appetite suppression are developed by Elira.
Annual revenue - Latest available
Total funding $8.6M 7 rounds
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 7 Brand Intelligence

About Elira

Elira is a company based in St. Louis (United States) founded in 2004. Elira has raised $8.63 million across 7 funding rounds. Elira operates in a competitive market with competitors including EnteroMedics, Aspire Bariatrics, Endosphere, Melcap Systems and AspireAssist, among others.

  • Headquarter St. Louis, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $8.63 M (USD)

    in 7 rounds

  • Latest Funding Round
    $1.25 M (USD), Series A

    Dec 27, 2022

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Elira

Elira has successfully raised a total of $8.63M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $1.25 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Elira

Investments
Premium access

Investment portfolio details for Elira

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Elira

Premium access

Detailed financials for Elira

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Elira Comparisons

Elira Primary company
Description
Wearable neurostimulation devices for appetite suppression a...
Location
St. Louis, United States
Founded Year
2004
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Elira

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Elira

Elira operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EnteroMedics, Aspire Bariatrics, Endosphere, Melcap Systems and AspireAssist, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Satiety induction through vagal nerve block
Locked Locked Locked
Aspire Bariatrics is focused on weight loss solutions.
Locked Locked Locked
Provides a duodenal insertable implant for effective obesity treatment.
Locked Locked Locked
Develops wireless ingestible capsules and apps for non-invasive weight management solutions.
Locked Locked Locked
Offers a device for effective treatment of obesity.
Premium access

Detailed competitors of Elira

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Elira

Premium access

Complete news archive for Elira

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Elira

Elira was founded in 2004 and raised its 1st funding round 11 years after it was founded.

Elira is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.

Elira is a funded company, having raised a total of $8.63M across 7 funding rounds to date.

Elira was founded in 2004 in St. Louis, United States, and operates in the health technology sector. A wearable patch called ELIRA 2, based on neurostimulation, is being developed to influence eating habits through appetite suppression. The companys focus remains on creating non-invasive devices aimed at managing dietary behaviors, with operations centered in the U.S. market.

Elira's top competitors include EnteroMedics, Aspire Bariatrics and Endosphere.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available